Today Eli Lilly and Co. announced the FDA approval of Cymbalta (duloxetine HCI) for the management of fibromyalgia. Cymbalta is the first serotonin-norepinephrine reuptake inhibitor with proven efficacy for reducing pain in patients with fibromyalgia. This makes Cymbalta the second medication ever to be approved for fibromyalgia, following Lyrica’s approval in June 2007.
This is exciting news for fibromyalgia patients. No single medication or treatment is right for everyone, so the mor...
...U.S. Food and Drug Administration requesting that Cymbalta (duloxetine) be approved for the... Read more »
...the literature as not causing weight gain include Cymbalta and Serzone. If you find... Read more »
...(e.g., nausea, vomiting, headache, numbness, tingling, nightmares) may occur if you suddenly... Read more »
NEW YORK (Ivanhoe Broadcast News) -- Osteosarcoma is a rare childhood bone cancer that can be fatal because it spreads to the lungs. But now a new... Read summary »
(Ivanhoe Newswire) The terrorist attacks of September 11, 2001 seem to have taken a great mental toll on many people who lived in Lower Manhattan.... Read summary »
ST. LOUIS (Ivanhoe Broadcast News) -- Stem cell transplants can offer hope to people with cancer and other life-threatening illnesses. But the... Read summary »
SAN FRANCISCO (Ivanhoe Broadcast News) -- It's every soon-to-be parents' worst nightmare. Everything seems OK, and then during a prenatal check-up... Read summary »
WASHINGTON (Ivanhoe Broadcast News) -- Most days, you'll find Frances Goldstein at her easel. "I like to paint ... a lot," she says. Jacobo, her... Read summary »